申请人:Hanmi Pharm. Co., Ltd.
公开号:EP3141552A1
公开(公告)日:2017-03-15
The present invention relates to a thienopyrimidine derivative of generic formula (I), a pharmaceutically acceptable salt thereof, a hydrate thereof, and a solvate thereof having an improved inhibitory activity for protein kinases, and a pharmaceutical composition for preventing or treating an abnormal cell growth disorder comprising same as an active ingredient.
本发明涉及一种通式(I)的噻吩嘧啶衍生物、其药学上可接受的盐、其水合物和其溶液,其对蛋白激酶的抑制活性有所提高,还涉及一种用于预防或治疗异常细胞生长紊乱的药物组合物,其活性成分包含上述物质。